scispace - formally typeset
Journal ArticleDOI

Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects.

Deepa S. Mandlik, +1 more
- 04 Mar 2021 - 
- Vol. 18, Iss: 2, pp 183-226
TLDR
This review has summarized the active phytoconstituents, pharmacologic activities (preclinical and clinical), mechanisms of action, potential beneficial applications, marketed formulations and safety and toxicity profile of W. somnifera.
Abstract
Withania somnifera, commonly known as “Ashwagandha” or “Indian ginseng” is an essential therapeutic plant of Indian subcontinent regions. It is regularly used, alone or in combination with other pl...

read more

Citations
More filters
Journal ArticleDOI

Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management

TL;DR: In this article, the authors presented a research synthesis of in silico, in vitro, in vivo, and clinical studies on Withania somnifera (L.) Dunal (WS) and discussed its potential for prophylaxis and management of COVID-19.
Journal ArticleDOI

Withania somnifera as a potential future drug molecule for COVID-19.

TL;DR: This research highlights the need to understand more fully the role of EMT in the development of central nervous system disease and its role in the immune response to chemotherapy.
Journal ArticleDOI

Phytotherapy for treatment of cytokine storm in COVID-19.

TL;DR: Experimental validation of the effectiveness of these natural compounds to prevent or reduce the cytokine storm might be beneficial as an adjunct treatment of SARS-CoV-2.
Journal ArticleDOI

Withania somnifera (L.) Dunal: Phytochemistry, structure-activity relationship, and anticancer potential.

TL;DR: An updated review on the anticancer potential and mechanisms of action of the major bioactive components of W. somnifera, including withanolides, withaferin A and withanone, is presented in this paper .
Journal ArticleDOI

Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19

TL;DR: A review highlights the medicinal and therapeutic potential of withanolides against COVID-19 and identifies WFA as one of the most interesting naturally occurring bioactive compounds that possess potent anti-tumorigenic, antiinflammatory, pro-apoptotic, anti-angiogenic, and anti-invasive activities.
References
More filters
Journal Article

Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.

TL;DR: Preliminary studies have found various constituents of ashwagandha exhibit a variety of therapeutic effects with little or no associated toxicity, indicating this herb should be studied more extensively to confirm these results and reveal other potential therapeutic effects.
Journal ArticleDOI

A Textbook of Pharmacognosy

W. O. Howarth
- 01 Sep 1945 - 
TL;DR: This text-book of pharmacognosy has grown from a laboratory manual intended for use in practical classes, and now comprises the requirements for the Chemist and Druggist Qualifying Examination of the Pharmaceutical Society of Great Britain.
Journal ArticleDOI

Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine.

TL;DR: Some of the problems in evaluation of adaptogens which have precluded their inclusion as clinically useful drugs are discussed.
Journal ArticleDOI

Steroidal lactones from Withania somnifera, an ancient plant for novel medicine.

TL;DR: An overview of the chemical structures of triterpenoid components and their biological activity is presented, focusing on two novel activities, tumor inhibition and antiangiogenic properties of withaferin A and the effects of withanolide A on Alzheimer's disease.
Related Papers (5)
Trending Questions (2)
Is ashwagandha safe during pregnancy?

The answer to the query is not mentioned in the provided paper. The paper is about the pharmacological evaluation of Ashwagandha, highlighting its healthcare claims, safety, and toxicity aspects.

What are the safety concerns with Ashwagandha?

The paper evaluates the safety and toxicity aspects of Ashwagandha, but specific safety concerns are not mentioned in the abstract.